PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7707259

Radical prostatectomy: a case study.

J S Carapella
View original source ↗Export metadata ↓

Abstract

Radical prostatectomy is widely used to treat prostate cancer. Complications such as hemorrhage, hypothermia, impotence and pain can occur with this surgery. This case study discusses preoperative autologous blood donation as well as explains staging and grading systems used for prostate cancer. Fluid management also is reviewed. Postoperative treatment of the patient with cancer of the prostate is rapidly changing. Emphasis is placed on the follow up of and rationale behind treatment after surgery.

Explore related subjects

AdenocarcinomaHumansMaleMiddle AgedProstatectomyProstatic NeoplasmsCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J S Carapella. 1994. Radical prostatectomy: a case study.. https://pubmed.ncbi.nlm.nih.gov/7707259/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta -catenin release.

The G12 subfamily of heterotrimeric G proteins, comprised of the alpha-subunits Galpha12 and Galpha13, has been implicated as a signaling component in cellular processes ranging from cytoskeletal changes to cell growth and oncogenesis. In an attempt to elucidate specific roles of this subfamily in cell regulation, we sought to identify molecular targets of Galpha12. Here we show a specific interaction between the G12 subfamily and the cytoplasmic tails of several members of the cadherin family of cell-surface adhesion proteins. Galpha12 or Galpha13 binding causes dissociation of the transcriptional activator beta-catenin from cadherins. Furthermore, in cells lacking the adenomatous polyposis coli protein required for beta-catenin degradation, expression of mutationally activated Galpha12 or Galpha13 causes an increase in beta-catenin-mediated transcriptional activation. These findings provide a potential molecular mechanism for the previously reported cellular transforming ability of the G12 subfamily and reveal a link between heterotrimeric G proteins and cellular processes controlling growth and differentiation.

Adenocarcinoma↗